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Glycogen synthase kinase 3 (GSK3) is emerging as a key regulator of several aspects of
neuronal morphogenesis including neuronal polarization, axon growth, and axon branch-
ing. Multiple signaling pathways have been identiﬁed that control neuronal polarization,
including PI3K, Rho-GTPases, Par3/6, TSC–mTOR, and PKA–LKB1. However, how these
pathways are coordinated is not clear. As GSK3 signaling exhibits crosstalk with each of
these pathways it has the potential to integrate these polarity signals in the control neu-
ronal polarization. After neurons establish polarity, GSK3 acts as an important signaling
mediator in the regulation of axon extension and axon branching by transducing upstream
signaling to reorganization of the axonal cytoskeleton, especially microtubules. Here we
review the roles of GSK3 signaling in neuronal morphogenesis and discuss the underlying
molecular mechanisms.
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During neural development, differentiated neurons undergomul-
tiple steps of morphogenesis, including directed neuronal migra-
tion, neuronal polarization, axon outgrowth, axon guidance, and
axonbranching, to form the architectural basis of neural circuits.A
common cellular process underlying these morphogenetic events
is reorganization of the neuronal cytoskeleton directed by extra-
cellular cues. Therefore, understanding how extracellular signals
are translated into cytoskeletal reorganization is a key question
in study of neuronal morphogenesis. Glycogen synthase kinase 3s
(GSK3s), including GSK3α and GSK3β, are key components of
the canonical Wnt signaling pathway. Recent studies indicate that
GSK3s are also key upstream regulators of neuronal microtubules,
as a number of microtubule-binding proteins (MBPs) are GSK3
substrates. Further, in addition to canonical Wnt ligands GSK3
activity is modulated by many other extracellular factors and their
associated downstream pathways. Therefore, GSK3 is emerging as
a major signaling mediator that functions to orchestrate each step
of neuronal morphogenesis. In this review, we summarize and
evaluate studies that show the involvement of GSK3 signaling in
neuronal polarization, axon growth, and axon branching. We also
discuss the potential molecular and cellular mechanisms by which
GSK3 signaling regulates these morphogenetic processes.
GSK3 SIGNALING IN NEURONAL POLARIZATION
The development of axon/dendrite polarity forms the structural
basis for directional transmission of neural activities between neu-
rons. In the past decade, the cellular and molecular mechanisms
by which neuronal polarity is regulated have been extensively
studied (Barnes and Polleux, 2009). Based on observations in a
seminal in vitro model (Craig and Banker, 1994), we know that
neuronal polarization involves multiple cellular steps. First, an
intracellular signal is locally activated in one of the unpolarized
neurites that breaks the cell symmetry and initiates the polariza-
tion process. Additional polarity determinants, likely downstream
of the initiation signal, are then asymmetrically accumulated in
the same neurite, which later becomes the axon. Second, such
asymmetric signaling then triggers reorganization of cytoskeletal
elements (actin ﬁlaments and microtubules) in the future axon
and leads to its preferential growth. Lastly, sustained activation
of multiple cellular processes speciﬁcally in the axon, including
polarized protein/membrane transport and local protein trans-
lation/degradation, act to maintain the established asymmetry
and axon extension. At the same time, complementary signaling
occurs in the dendrites to suppress neurite extension. During the
past decade, many intracellular signaling pathways and molecules
have been identiﬁed that control these polarization steps. These
include the PI3K pathway, the Rho-GTPase pathways, the Par3/6
pathway, the TSC–mTOR pathway, and the PKA–LKB1 pathway
(Shi et al., 2003; Nishimura et al., 2004, 2005; Schwamborn and
Puschel, 2004; Barnes et al., 2007; Shelly et al., 2007; Choi et al.,
2008; Li et al., 2008). However, how these pathways regulate neu-
ronal polarization in a coordinated manner is not clear. GSK3
signaling has been shown to crosstalk with each of these pathways,
suggesting that it may function to coordinate and integrate polar-
ity signaling. Here, we review the roles of GSK3 signaling and its
potential link to established polarity pathways during each step of
neuronal polarization (Figure 1).
BREAKING THE SYMMETRY TO ESTABLISH NEURONAL POLARITY
Before polarization, intracellular signaling molecules that con-
trol polarization are distributed evenly among unpolarized neu-
rites. The breaking of cell symmetry is initiated by local acti-
vation of intracellular signals in one of the neurites, which
later develops into the axon. One such symmetry-breaking sig-
naling molecule is PI3K (Shi et al., 2003), which in neurons
is a key downstream signaling mediator of receptor tyrosine
kinases (RTKs; Reichardt, 2006). Activated PI3K phosphory-
lates phosphatidylinositol-4,5-bisphosphate (PIP2) to produce
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FIGURE 1 | GSK3 plays pivotal roles in the establishment and
maintenance of neuronal polarization. Neuronal polarization process
begins by breaking cell symmetry, which is thought to be initiated by local
activation of intracellular signaling in the nascent axon. Symmetry-breaking
signals might involve conﬁned activation of cell surface receptors, such as G
protein-coupled receptors (GPCRs) or receptor tyrosine kinases, in the
growth cone of the future axon. Several lines of evidence suggest GSK3 as
a crucial node molecule of the initial symmetry-breaking pathways, such as
the protein kinase A (PKA)–LKB1 pathway, the PI3K–partition defective
protein (Par) pathway, and theWnt–disheveled (Dvl) pathway. Local
activation of symmetry-breaking signals leads to the reorganization of
cytoskeletal elements, thereby establishing neuronal polarity. GSK3 might
serve as a key molecule in the coordination of cytoskeletal elements by
controlling microtubule dynamics and assembly via regulation of several
microtubule-binding proteins (MBPs). Microtubule afﬁnity-regulating kinase
(MARK) has also been suggested to function downstream of the Par
complex to control neuronal polarization by regulating MBPs. Once the
symmetry is broken, maintaining the selective extension one neurite – the
future axon – can be controlled by multiple mechanisms, including local
protein synthesis and degradation, and selective transport mechanisms.
GSK3 has been implicated in the local protein synthesis pathway by
controlling the activity of the mammalian target of rapamycin (mTOR)
complex via phosphorylating tuberous sclerosis 2 (TSC2), but the exact
roles of the players involved and their regulation in the context of axon
growth await to be determined. Local protein degradation through activation
of the ubiquitin–proteasome system (UPS) is another possible mechanism
to maintain asymmetrical accumulation of polarity proteins. Molecules that
control GSK3 activity, such as Akt, PAR3/6, and LKB1, have been suggested
as targets of the local degradation process. In addition, accumulating
evidence suggests that protein levels of multiple downstream substrates of
GSK3 are controlled by phosphorylation-dependent proteolytic degradation.
Future studies are required to determine whether GSK3 activation in
dendrites plays a part in maintaining the polarized growth of the axon and
restricting the growth of the dendrites by controlling local protein
degradation. Finally, selective delivery of membrane and cytoskeletal
components and signaling proteins into deﬁned compartments is an
important mechanism to maintain neuronal polarity. GSK3 phosphorylates
several motor proteins and polarity proteins to control their selective
transport and localization. See text for further details for each of the
mechanism depicted in the ﬁgure.
phosphatidylinositol-3,4,5-trisphosphate (PIP3) in the cell mem-
brane, which then activates its downstream targets, such as AKT
and Rho-GTPases (Cantley, 2002). Local activation of PI3K and
the subsequent accumulation of PIP3 in the neurite that becomes
the future axon have been shown to be early markers of neuronal
polarization (Menager et al., 2004). Several lines of evidence
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suggest that GSK3 inactivation functions downstream of the
PI3K–PIP3 pathway to control neuronal polarization. Thus, global
inhibition of GSK3 with pharmacological inhibitors induces mul-
tiple axon formation, whereas overexpression of an active mutant
of GSK3β (GSK3β-S9A) prevents axon formation (Jiang et al.,
2005; Yoshimura et al., 2005). Importantly, overexpression of
PTEN (a phosphatase that dephosphorylates PIP3) blocks neu-
ronal polarization, which can be rescued by direct inhibition of
GSK3 with pharmacological inhibitors (Jiang et al., 2005). Con-
versely, knocking downof PTEN inducesmultiple axon formation,
which can be antagonized by overexpression of the active GSK3
mutant. However, how PI3K inactivates GSK3 to control neuronal
polarization is still not clear.
One way that PI3K inactivates GSK3 is through AKT-mediated
phosphorylation of GSK3 at an N-terminal domain serine residue
(Cross et al., 1995). In support of the importance of Akt regu-
lation, phosphorylated GSK3β co-localizes with phosphorylated
AKT in the axon (Zhou et al., 2004; Jiang et al., 2005). More-
over, overexpression of a myristoylated active form of AKT leads
to multiple axon formation which is antagonized by GSK3β-S9A
expression (Jiang et al., 2005). However, neurons from theGSK3α-
S21A/GSK3β-S9A double knockin mice, in which GSK3 cannot
be phosphorylated by AKT, show no defect in neuronal polar-
ization (Gartner et al., 2006), arguing against the idea that PI3K
controls neuronal polarization via AKT-mediated GSK3 inactiva-
tion. PI3K has also been shown to regulate neuronal polarization
through the Rho-GTPase Cdc42 and the subsequent activation
of the Par3/6 cell polarity pathway (Shi et al., 2003). Par3/6 are
mammalian homologs of the partition defective protein 3/6 of
C. elegans. Interestingly, during directed cell migration locally
activated Cdc42 at the cell leading edge can recruit the Par3/6
complex, which subsequently interacts with GSK3 and leads to
GSK3 inactivation (Etienne-Manneville and Hall, 2003). There-
fore, an alternative way that PI3K might inactivate GSK3 during
neuronal polarization is via the Cdc42–Par3/6 pathway (Figure 1;
Hur and Zhou, 2010). Further studies are required to test this
hypothesis in neurons during polarization. How Par3/6 regulates
GSK3 activity is unclear. A recent study showed that GSK3 activity
could be regulated byDISC1 through protein–protein interactions
independent of GSK3 serine phosphorylation (Mao et al., 2009).
It is possible that Par3/6 also regulate GSK3 activity via the similar
mechanism (Hur and Zhou, 2010). Interestingly, Par3 can directly
bind to PI3K and enhance its activity (Itoh et al., 2010), suggesting
that increased serine phosphorylation of GSK3 by Akt might be
downstream of GSK3 inactivation by Par3. As a result, the levels of
GSK3 serine phosphorylation can still be used as an indicator of
GSK3 activity, even though GSK3 phosphorylation may not be a
major mechanism by which GSK3 activity is inactivated (Hur and
Zhou, 2010).
In addition to PI3K, another signaling molecule also activated
downstream of RTKs or GPCRs that may act to break symmetry
and initiate polarization is PKA. A recent study of neuronal polar-
ization using live cell imaging of a cAMP biosensor suggests that
local elevation of cAMP and activation of PKA in one undiffer-
entiated neurite is an early signal to establish neuronal polarity
(Shelly et al., 2010). The downstream mediator of PKA in reg-
ulation of neuronal polarization is the serine/threonine kinase
LKB1 (Figure 1), which is the homolog of the partition defective
protein 4 (Par4) of C. elegans (Barnes et al., 2007; Shelly et al.,
2007). Activated PKA phosphorylates LKB1 and elevates its pro-
tein level. LKB1 then phosphorylates and activates SAD kinases,
which have a similar kinase domain to that of partition defective
protein 1 (Par1) and its mammalian homologs, MARK1–MARK4
(Kishi et al., 2005). Activated SAD kinases are believed to reg-
ulate neuronal polarization via the microtubule-binding protein
Tau (Kishi et al., 2005). Interestingly, activation of PKA in neu-
rons induces increased phosphorylation of both LKB1 and GSK3
(Shelly et al., 2010). Moreover, depletion of LKB1 abolishes GSK3
phosphorylation in all unpolarized neurites (Asada et al., 2007).
These results suggest that GSK3 acts downstream of the PKA–
LKB1 pathway to control neuronal polarization. Consistent with
this idea, theXenopus homolog of LKB1, XEEK1, is able to directly
interact with GSK3β in vivo (Ossipova et al., 2003; Figure 1). In
addition, a recent study showed that LKB1 inactivates GSK3 in
mammalian neurons to control neuronal migration (Asada and
Sanada, 2010). Taken together, these results suggest that GSK3may
act downstream of PI3K and PKA to establish neuronal polarity
via direct interaction with Par3/6 and LKB1, respectively. While
the cAMP–PKA pathway promotes axon formation during the
symmetry-breaking process, reciprocal activation of the cGMP
pathway acts to promote dendrite formation. A new study showed
that semaphorin 3A acts upstream of cGMP to induce dendrite
formation (Shelly et al., 2011). In contrast to the cAMP–PKA
pathway that leads to GSK3 inactivation, semaphorin 3A has been
shown to activateGSK3 (Eickholt et al., 2002). Consistent with this
observation, semaphorin 3A treatment antagonizes PKA-induced
GSK3 phosphorylation (Shelly et al., 2011). Together, these studies
indicate that reciprocal regulation of cAMP/cGMP signaling con-
trols axon/dendrite formation via opposite modulation of GSK3
activity.
POLARIZED CYTOSKELETAL REORGANIZATION PRECEDING
ASYMMETRICAL AXON EXTENSION
After polarity signals are accumulated in the future axon but before
asymmetric axon extension occurs, the cytoskeletal elements in the
future axon reorganize to complete the establishment of neuronal
polarity (Witte and Bradke, 2008). Speciﬁcally, the actin ﬁlaments
(F-actin) in the growth cone of the future axon become more
dynamic than those in growth cones of other neurites (Bradke
and Dotti, 1999). In addition, the microtubules in the future
axon are preferentially stabilized (Witte et al., 2008). Importantly,
these polarized reorganizations of F-actin and microtubules per se
are sufﬁcient to establish neuronal polarity, indicating that they
play instructive roles in establishing neuronal polarization, rather
than simply supporting axon extension (which will be discussed
later in this review). However, how such polarized cytoskeletal
rearrangement is regulated by upstream polarity signals remains
unclear.
Among all the polarity pathways, GSK3 signaling is the best
candidate for transducing the polarity signal into cytoskeletal
reorganization, in particular microtubule stabilization (Zhou and
Snider, 2005; Hur and Zhou, 2010). Many MBPs involved in neu-
ronal polarization areGSK3 substrates, such as collapsin response-
associated protein 2 (CRMP2; Cole et al., 2004), adenomatous
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polyposis coli (APC), Tau, and MAP1b. The function of these
MBPs is to promotemicrotubule assembly and stability, and phos-
phorylation of them by GSK3 abolishes their ability to interact
withmicrotubules. As a result, polarity signals can stabilize micro-
tubules in the future axon by inactivation of GSK3. For instance,
inhibition of GSK3 enhances the interactions between CRMP2
and tubulin dimers, which subsequently promotes microtubule
assembly and stability. Overexpression of CRMP2 is sufﬁcient to
induce the formation of multiple axons (Yoshimura et al., 2005).
Moreover, knocking down of CRMP2 antagonizes multiple axon
formation induced by global GSK3 inactivation, indicating the
CRMP2 acts downstream of GSK3 inactivation (Yoshimura et al.,
2005). The microtubule plus end tracking protein (+TIP) APC
localizes at the tips of all unpolarized neurites before neuronal
polarization, and later becomes enriched in the growth cone of the
future axon (Votin et al., 2005). Binding of APC to themicrotubule
plus ends functions to stabilize microtubules, a process negatively
regulated by GSK3-mediated phosphorylation (Zumbrunn et al.,
2001; Zhou et al., 2004). Therefore, local GSK3 inactivation in
the future axon promotes the binding of APC to the microtubule
plus ends, leading to asymmetricalmicrotubule stabilization in the
future axon. However, neurons from APC knockout mice do not
show polarization defects (Yokota et al., 2009), suggesting com-
pensatory effect of its homolog APC-L (Nakagawa et al., 1998) or
redundant function of other microtubule +TIPs.
How polarized cytoskeletal reorganization directs neuronal
polarization is unknown. One potential mechanism is that it may
affect post-translationalmodiﬁcation of microtubules,which then
facilitate the binding of motor proteins to the microtubules and
the subsequent directed transport (see detailed discussion below).
Indeed, activated kinesin-1 (or KIF5) is preferentially accumulated
in the future axon before polarized axon extension, and global
application of taxol or GSK3 inhibitors disrupts the polarized
targeting of kinesin-1 (Hammond et al., 2010).
MAINTAINING ASYMMETRICAL AXON EXTENSION
After the establishment of initial polarity, neurons require sus-
tained asymmetrical axon extension to complete the polarization
process. Many cellular processes have been suggested to maintain
such polarized axon extension, including polarized transport of
proteins and membrane, local protein translation, and local pro-
tein degradation. GSK3 signaling has been shown to be involved
in all of these processes.
Polarized transport of polarity determinants is important for
their sustained accumulation in the axon to direct asymmetrical
axon extension (Figure 1). Studies have shown that PI3K, PIP3,
and Par3 are all speciﬁcally transported to the axon by kinesins,
and that disruption of such transport blocks neuronal polariza-
tion (Shi et al., 2004; Horiguchi et al., 2006; Amato et al., 2011).
GSK3 can directly phosphorylate several kinesin light chains and
thus regulate the interactions between kinesins and their trans-
ported cargoes (Morﬁni et al., 2002, 2004; Szebenyi et al., 2002).
In addition, many of the kinesin superfamily proteins have con-
served GSK3 consensus sites (Taelman et al., 2010). Thus GSK3
may be a major regulatory factor of kinesin function. In support
of this idea, Par3 is speciﬁcally delivered to the axon by form-
ing a protein complex with APC and KIF3A, and such polarized
transport requires local inactivation of GSK3 in the axon (Shi
et al., 2004). Moreover, a recent study demonstrated that activa-
tion of the energy-sensing adenosine 5′-monophosphate (AMP)-
activated protein kinase (AMPK) suppressed neuronal polariza-
tion by phosphorylating the kinesin light chain (KCL2) of theKIF5
protein, which functions to target PI3K to the axon (Amato et al.,
2011). Because GSK3 also phosphorylates KCL2 and negatively
regulates its function (Morﬁni et al., 2002, 2004), it is possible that
GSK3 inactivation promotes PI3K transport into the axon, thus
forming a positive feedback loop to control neuronal polarization.
Finally, PIP3 is speciﬁcally transported to the axon by KIF13B,
which is also a potential GSK3 substrate (Horiguchi et al., 2006).
In addition to regulating transport of proteins, GSK3 also regu-
lates polarized axonal transport of vesicles containing membrane
components (Morﬁni et al., 2004; Gartner et al., 2006). GSK3β
is speciﬁcally accumulated in the Golgi region of hippocampal
neurons in a membrane-bound form. Global inhibition of GSK3
with inhibitors disrupts preferential trafﬁc of membrane contain-
ing vesicles to the axon, and directs them symmetrically toward
all neurites (Gartner et al., 2006). However, how GSK3 regulates
membrane transport is unknown. Together, these studies suggest
that GSK3 functions to maintain asymmetrical axon extension via
regulation of directed axonal transport.
Local and asymmetrical protein translation of polarity mol-
ecules has been reported to control neuronal polarization
(Figure 1). One important pathway that regulates protein transla-
tion is the TSC–mTOR pathway (Ma and Blenis, 2009). Activation
of AKT activates Rheb and the subsequent mammalian target
of rapamycin (mTOR) kinase by inactivating their negative reg-
ulators TSC1/2. Activated mTOR then phosphorylates multiple
translation regulators, such as ribosomal S6 kinase (S6K) and
translation initiation factor 4E binding protein (4EBP), to initiate
protein translation. During neuronal polarization phosphorylated
S6K and 4EBP are enriched in the axon (Morita and Sobue, 2009),
indicating local activation of mTOR signaling. Further, overex-
pression of constitutively activatedRheb and S6K inducesmultiple
axon formation, whereas dominant negative Rheb and S6K block
neuronal polarization (Morita and Sobue, 2009). Importantly,
genetic knockout of TSC1orTSC2 leads to the formation of multi-
ple axons in vitro and in vivo (Choi et al., 2008). Evidence showing
direct involvement of GSK3 signaling in the TSC–mTOR path-
way during neuronal polarization is lacking. However, one study
has shown that GSK3 directly phosphorylates TSC2 after AMPK-
mediated priming, leading to inhibition of the mTOR pathway
(Inoki et al., 2006). Conversely, inactivation of GSK3 is sufﬁcient
to activate mTOR-dependent protein translation. Therefore, it is
possible that local inactivation of GSK3 in the axon plays a role in
regulation of local translation through the mTOR pathway. Sev-
eral polarity-related proteins are locally translated in the axon,
including SAD kinase, CRMP2, Tau, and Par3 (Inoki et al., 2006;
Choi et al., 2008; Hengst et al., 2009). Very interestingly, as men-
tioned earlier CRMP2 and Tau are GSK3 substrates, whereas Par3
acts upstream of GSK3, indicating additional examples of positive
feedback loops involving GSK3 signaling through local protein
translation.
Several studies have shown that local protein degradation via
the ubiquitin–proteasome system (UPS) also controls neuronal
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polarization (Figure 1). Local degradation of polarity determi-
nants in minor neurites is necessary to maintain their asymmetri-
cal accumulation in the axon. In support, UPS has been shown
to control the local degradation of AKT, Par3/6, and LKB1 in
minor neurites during neuronal polarization, and global inhibi-
tion of UPS results in the formation of multiple axons (Yan et al.,
2006; Cheng et al., 2011). Conversely, local degradation of RhoA (a
suppressor of axon extension) is also required to maintain asym-
metrical axon extension (Cheng et al., 2011). Although the GSK3
level in neurons is not regulated by UPS-mediated protein degra-
dation, inhibition of UPS increases the level of phosphorylated
GSK3β (Yan et al., 2006), suggesting that GSK3 inactivation might
be involved in multiple axon formation induced by UPS inhibi-
tion. In support of this idea, the best studied function of GSK3 is
regulation of the degradation of β-catenin in the canonical Wnt
pathway via UPS (Hur and Zhou, 2010). A recent study demon-
strates that GSK3 regulates UPS-mediated degradation of a much
broader list of proteins (Kim et al., 2009a; Xu et al., 2009), raising
the possibility that GSK3 may regulate the degradation of polarity
determinants. For instance, Par3 and the aforementioned Par1
homologs, MARK1-4, contain three and six consecutive GSK3
phosphorylation sites (Taelman et al., 2010), respectively. It will be
extremely interesting in the future to investigatewhether these pro-
teins can be regulated by GSK3-dependent,UPS-mediated protein
degradation.
In summary, evidence is emerging that GSK3 is a key
signal-integrating molecule that coordinates neuronal polariza-
tion by transducing early symmetry-breaking signaling, control-
ling cytoskeletal reorganization, andmodulating polarized protein
distribution. How GSK3 is asymmetrically regulated during neu-
ronal polarization is not fully understood. One possible mecha-
nism is that upstream regulators of GSK3 is locally distributed or
activated. Another potential mechanism is local sequestration of
GSK3 by scaffolding proteins. For instance, GSK3 has been shown
to bind to the A-kinase anchoring proteins 220 (AKAP220), which
mediates localized interaction betweenGSK3 andPKA (Tanji et al.,
2002). In addition, a recent study showed that a GSK3 interact-
ing protein could also function as an AKAP (Hundsrucker et al.,
2010).
GSK3 SIGNALING IN AXON GROWTH
After the neuron polarizes, the axon may extend a long distance
to reach its targets and form synaptic connections. Axon growth
is supported by extracellular factors, which transduce their sig-
nals into coordinated gene expression in the neuronal soma and
local assembly of cytoskeleton and membrane in the growth cone
(Zhou and Snider, 2006). GSK3 is a key mediator that translates
extracellular signals into controlled axon assembly. Here we sum-
marize how extracellular factors regulateGSK3 activity anddiscuss
howGSK3 controls cytoskeletal reorganization in the growth cone
during axon elongation.
GSK3 IS REGULATED BY MULTIPLE EXTRACELLULAR FACTORS THAT
CONTROL AXON GROWTH
The most studied extracellular factors that support axon
growth are growth factors, such as neurotrophins, IGF-1, and
GDNF (Zhou and Snider, 2006). All these factors initiate their
intracellular signals through RTKs. One of the major downstream
mediators of RTKs is PI3K which plays a key role in controlling
axon growth and is the best-known regulator of GSK3 signaling.
Treatment of embryonic dorsal root ganglion (DRG) neuronswith
nerve growth factor (NGF) leads to PI3K activation and increased
phosphorylation of GSK3β at its N-terminal serine-9 (Zhou et al.,
2004). Functionally, overexpression of the activemutant of GSK3β
(GSK3β-S9A) blocks NGF-induced axon growth. These results
indicate that NGF inactivates GSK3 downstream of PI3K to pro-
mote axon growth. However, other studies have shown that NGF
treatment leads to increased phosphorylation of MAP1b at its
GSK3 sites, indicating that NGF also activates GSK3 (Goold and
Gordon-Weeks, 2003; Trivedi et al., 2005). In contrast to GSK3β
inactivation downstream of PI3K,GSK3 activation, and the subse-
quent phosphorylation of MAP1b is regulated by ERK1/2 (Goold
and Gordon-Weeks, 2005), another major signaling mediator
downstream of RTKs. Global application of netrin, a well-studied
attractive axon guidance cue, also promotes axon growth through
its receptor deleted in colon cancer (DCC) and the activation of the
ERK1/2 pathway (Forcet et al., 2002). Similar to NGF, treatment
of cultured neurons with netrin increased the level of phospho-
rylated MAP1b at its GSK3 site (Del Rio et al., 2004). Moreover,
netrin treatment led to increased levels of GSK3β phosphoryla-
tion at both tyrosine-216, which is often associated with GSK3
activation, and serine-9, which indicates GSK3 inactivation (Del
Rio et al., 2004). Thus, both NGF and netrin seem to inactivate
and activate GSK3 in same cells downstream of PI3K and ERK1/2,
respectively. One potential explanation is that regulation of GSK3
by NGF or netrin in neurons is segregated spatially or temporary
allowing inactivation and activation at different times or places
inside cell.Another possible explanation is that phosphorylationof
GSK3β, either at serine-9 or at tyrosine-216, may not be a reliable
indicator of GSK3 activity (Hur and Zhou, 2010). Future stud-
ies to directly examine GSK3 activity in live cells are required to
test these hypotheses. Finally, one study has shown thatWnt3a can
promote axon growth of mouse embryonic DRGneurons through
its atypical receptor Ryk and the canonicalWnt pathway (Lu et al.,
2004), suggesting the involvement of GSK3. However, the role of
GSK3 inWnt3a-induced axon growth has not been directly tested.
GSK3 CONTROLS AXON ELONGATION VIA REGULATION OF THE
GROWTH CONE MACHINERY
Axon elongation requires continuous addition of microtubules to
the growing end, which is controlled by coordinated regulation
of microtubule dynamics and actin reorganization in the growth
cone (Zhou and Snider, 2006). Actin ﬁlaments are enriched in
the peripheral domain (P-domain) of the growth cone, and are
organized into actin bundles and actin meshwork. Microtubules
project from the axon shaft to the central region (C-domain) of
the growth cone in a bundled form. At the end of the micro-
tubule bundles, individual microtubules splay apart and a subset
of microtubules invade the actin-rich P-domain. Axon elongation
is ultimately achieved through microtubule assembly at the nerve
growth cones, in which a key step is microtubule extension toward
the growth cone leading edge. Several factors have been shown to
control microtubule extension in the growth cone. First, micro-
tubules undergo cycles of polymerization and depolymerization, a
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process called dynamic instability (Burbank andMitchison, 2006).
There is an extensive list of microtubule or tubulin-binding pro-
teins that act to regulate this process (Poulain and Sobel, 2010).
For instance, some proteins can bind to the tubulin dimers and
control tubulin polymerization (e.g., CRMP2) or depolymeriza-
tion (e.g., stathmin). In addition, classic microtubule associated
proteins (MAPs, e.g., Tau and MAP1b) bind along the micro-
tubule lattices, whereas microtubule +TIPs (e.g., APC, EB1/3,
and CLASP1/2) speciﬁcally interact with the plus ends, both of
which function to stabilize polymerizedmicrotubules. Lastly, there
are proteins that function to disassemble microtubules, includ-
ing microtubule severing proteins (e.g., katanin and spastin) and
microtubule depolymerases (e.g., MCAK/KIF2c). Second, micro-
tubule extension in the growth cone can be regulated by motor
protein-mediated transport of microtubule polymers. The plus
end directed motor kinesin-5, when anchored on the membrane,
has been shown to transport microtubules away from the leading
edge (Myers and Baas, 2007). Conversely, the minus end directed
motor dynein,when immobilized at the growth cone leading edge,
can pull the microtubules toward the leading edge (Myers et al.,
2006). Third, dynamic interactions between actin ﬁlaments and
microtubules in the growth cone are key processes that control the
microtubule extension. Actin bundles function to guide micro-
tubule extension toward the leading edge, whereas retrograde ﬂow
of actin meshwork powered by myosin II carries microtubules
rearward, thus acting as a dynamic barrier for microtubule exten-
sion (Schaefer et al., 2002; Zhou et al., 2002; Medeiros et al.,
2006).
Many of these cytoskeletal proteins are established GSK3 sub-
strates, including CRMP2, APC, CLASP1/2, MAP1b, Tau, stath-
min, and myosin II (Moreno and Avila, 1998; Kim et al., 2009a;
Hur and Zhou, 2010), or contain conserved GSK3 sites, such as
Katanin and KIF2c (Taelman et al., 2010). Thus, GSK3 is consid-
ered to be amajor signaling pathway that regulates the growth cone
machinery to drive axon elongation (Figure 2). However, because
these molecules play different, and sometimes opposing roles in
controlling cytoskeletal reorganization, the role of GSK3 signal-
ing in regulation of axon elongation is complex. Expression of the
active mutant of GSK3 (GSK3β-S9A) blocks axon growth (Zhou
et al., 2004, 2006), indicating that inactivation of GSK3 is necessary
for efﬁcient axon elongation. Surprisingly, inhibition of GSK3 has
been shown to either promote or impede axon growth depend-
ing on the extent of inhibition. Moderate GSK3 inhibition locally
at the growth cone is required for efﬁcient axon growth, whereas
more complete inhibition of GSK3 impedes axon growth (Kim
et al., 2006). One potential explanation for such pleiotropic effects
is that different degrees of GSK3 inhibition differentially affect dif-
ferent GSK3 substrates. In support of this idea, phosphorylation of
CRMP2 by GSK3 is more sensitive to GSK3 inhibition than phos-
phorylation of MAP1b (Kim et al., 2006). The identities of GSK3
substrates and the molecular mechanisms by which they speciﬁ-
cally mediate axon growth promotion or axon growth inhibition
upon GSK3 inactivation are being actively studied. Several mole-
cules have been identiﬁed that promote axon growth downstream
of GSK3 inactivation, including CRMP2 and APC. As mentioned
earlier, inhibition of GSK3 facilitates the binding of CRMP2 to
tubulin dimers and thus promotes axon growth by enhancing
FIGURE 2 | GSK3 is a key regulator of axon growth and branching. Axon
growth is thought to be initiated by activation of cell surface receptors upon
recognition of extrinsic cues, such as growth factors or other ligands. GSK3
has been suggested as a key molecule downstream of the PI3K pathway
and the cyclic guanosine monophosphate (cGMP) pathway to control axon
growth and/or branching. Upon activation of PI3K, GSK3 becomes
inactivated, leading to dephosphorylation of GSK3 substrates that control
the stability and dynamics of axonal microtubules. Dephosphorylation and
subsequent binding of adenomatous polyposis coli (APC) on microtubule
plus ends at certain locations along the axon enhances axonal branching,
whereas its enrichment at the growth cone leads to the promotion of axon
growth. CLASP, another substrate of GSK3 that binds to microtubules in
response to GSK3 inactivation, plays a role to regulate axon growth
downstream of GSK3. CLASP can both promote and inhibit axon growth
depending on its microtubule-binding activity, a property which is tightly
controlled by GSK3 activity. The cGMP pathway is another pathway that has
been shown to control axonal branching. In response to elevation of cGMP
by activation of guanylyl cyclase (GC), cGMP-dependent protein kinase G
(PrkG) becomes activated and functions to increase axon branching by
inactivating its substrate GSK3. In addition to the direct regulation of the
kinase activity, GSK3 activity can be controlled by other mechanisms, such
as regulation of its expression level. JNK-interacting protein (JIP) 3 has
been suggested to control the expression level of GSK3 at the transcription
level and/or by regulating mRNA stability. Down-regulation of JIP3, which
decreases GSK3 level, increases axonal branching by controlling the
phosphorylation status of doublecortin (DCX), a substrate of GSK3.
Coordinated regulation of multiple GSK3 substrates likely deﬁnes the
extent of axon growth and the locations at which axonal branching occurs.
microtubule polymerization in the growth cone (Yoshimura et al.,
2005). Similarly, dephosphorylated APC speciﬁcally bind to the
microtubule plus ends and function to stabilize polymerizing
microtubules, leading to increased microtubule extension in the
growth cone (Zhou et al., 2004).
Which substrates mediate impaired axon growth upon GSK3
inhibition to a greater extent? A new study has identiﬁed CLASP
as a mediator to block axon growth upon greater GSK3 inhibi-
tion (Hur et al., 2011). Speciﬁcally, the study showed that in the
absence of CLASP2, knocking down of GSK3 was unable to block
axon growth. The study also revealed that in nerve growth cones
CLASP could either track the microtubule plus ends or bind along
the microtubule lattice depending on its phosphorylation states
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mediated by GSK3. Interestingly, these two microtubule-binding
activities of CLASP regulate axon growth in an opposing man-
ner: themicrotubule lattice-binding activitymediates axon growth
inhibition via preventing microtubule protrusion into the growth
cone periphery, whereas the microtubule plus end-binding prop-
erty supports axon extension via stabilizing the growing ends of
axonal microtubules. As a result, when GSK3 activity becomes
strongly suppressed the binding of CLASP along the microtubule
lattice is increased,which subsequently inducesmicrotubule loop-
ing in the growth cone and blocks axon growth. In addition to
CLASP, other GSK3 substrates may also contribute to impaired
axon growth upon greater GSK3 inhibition. For instance, the reg-
ulatory light chain of myosin II (MLC)was recently identiﬁed to be
aGSK3 substrate, andphosphorylationofMLCbyGSK3promotes
its degradation through UPS (Kim et al., 2009a). Moreover, both
myosin IIA and IIB contain conserved GSK3 sites (Taelman et al.,
2010), suggesting GSK3 as an important regulator of myosin II
function. As a result, inhibition of GSK3 could block axon growth
by enhancingmyosin II activity in the growth cone. Indeed, similar
to that of CLASP2, knocking down of GSK3 was unable to block
axon growth when myosin II activity was inhibited (Hur et al.,
2011). Further study is needed in the future to show directly that
GSK3 phosphorylates myosin II and regulates its function in the
growth cone. Another potential substrate is MAP1b, which plays
a central role in maintaining microtubule dynamics in the growth
cone when phosphorylated by GSK3 (Goold et al., 1999). Because
microtubule dynamics are necessary for efﬁcient axon growth,
dephosphorylation of MAP1b upon greater inhibition of GSK3
may impede axon growth by reducing microtubule dynamics in
the growth cone (Owen and Gordon-Weeks, 2003). In support
of this idea, neurons from the MAP1b knockout mice show axon
growth defects and exhibitmarkedly reducedmicrotubule dynam-
ics in their growth cones (Gonzalez-Billault et al., 2002). Lastly, a
recent study has provided some evidence that CRMP4 might act
downstream of GSK3 inhibition to block axon growth (Alabed
et al., 2010). Dephosphorylation of CRMP4 increases its binding
to RhoA, a known negative regulator of axon growth.
In summary, abundant evidence indicates that an optimal
level of GSK3 activity is required for efﬁcient axon elongation
(Figure 2). Under such conditions, some substrates are dephos-
phorylated (e.g., CRMP2, APC) to promote microtubule exten-
sion, whereas others are phosphorylated (e.g., CLASP, MAP1b)
to maintain microtubule dynamics. Therefore, a delicate balance
between activation and inactivation of GSK3 acts to support the
most efﬁcient axon elongation by coordinating the functions of
multiple GSK3 substrates in the growth cone.
GSK3 SIGNALING IN AXON BRANCHING
When axons arrive at their destination, they usually form branches
to innervate multiple targets. As with axon elongation, axon
branching is tightly controlled by extracellular cues and their
downstream intracellular signaling pathways that mediate reorga-
nization of the axonal cytoskeleton to form axon branches. Based
onmorphology, axon branching can be grouped into arborization,
bifurcation, and interstitial branching (Gibson and Ma, 2011).
Time-lapse studies of live cells demonstrate that axon arborization
and bifurcation usually occur at the distal axon through growth
cone splitting, whereas interstitial branching forms de novo along
the axon shaft (Zhou et al., 2002; Portera-Cailliau et al., 2005;
Schmidt et al., 2007). Increasing evidence points to GSK3 as a
converging signaling mediator that transduces branching signals
into regulated cytoskeletal rearrangement at the growth cone or
along the axon shaft. Here we review previous studies that show
the involvement of GSK3 in axon branching and discuss the poten-
tial cellular mechanisms by which GSK3 signaling controls axon
branching (Figure 2).
GSK3 functions have been carefully studied in sensory axons of
DRG neurons that bifurcate at the dorsal root entry zone (DREZ)
when they enter the spinal cord during development. Recent stud-
ies have identiﬁed C-type natriuretic peptide (CNP; also known
as NPPC) as the extracellular factor that controls DRG axon bifur-
cation (Schmidt et al., 2009; Zhao and Ma, 2009). Downstream
of CNP, cGMP, and cGMP-dependent protein kinase G1 (PrkG1)
act to control axon branching via GSK3 inactivation (Zhao et al.,
2009). Speciﬁcally, axon branching of cultured embryonic DRG
neurons was substantially increased upon treatment of CNP or
cGMP (8-Br-cGMP), and the effect was abolished in neurons from
the PrkG1 knockout mice (Zhao andMa, 2009). Moreover, PrkG1
inhibits GSK3β by binding and directly phosphorylating GSK3β
at its serine-9 residue (Zhao et al., 2009). Importantly, cGMP-
induced axon branching can be antagonized by overexpression of
the active mutant of GSK3β (GSK3β-S9A), conﬁrming that GSK3
inactivation is necessary for the cGMP–PrkG1 pathway to induce
axon branching. As discussed earlier, serine phosphorylation may
not be a major mechanism by which GSK3 is inactivated. Thus, it
will be interested to examine if DRG axon bifurcation in the spinal
cord during development is normal in the GSK3α-S21A/GSK3β-
S9A double knockinmice, or to determine if PrkG1 is able to inac-
tivate GSK3 via alternative mechanisms. After entering the spinal
cord, axons of the NT3-responsive neurons in the DRG project
ventrally and form terminal arborizations upon contact with the
motor neurons, their synaptic targets.Wnt3 secreted by the motor
neurons has been shown to cause such axon branching, suggesting
that inhibition of GSK3 through the canonicalWnt pathwaymight
be involved (Krylova et al., 2002). Indeed, inhibition of GSK3 with
pharmacological inhibitors induced similar axonal arborization,
mimicking the effect of Wnt3 (Krylova et al., 2002). In addition to
the central axons in the spinal cord, the peripheral axons of sensory
neurons also form terminal branches within their targeting areas
(e.g., skin). The axon guidance cue Slit has been shown to play an
important role in regulation of such peripheral axon branching of
sensory neurons (Ma and Tessier-Lavigne, 2007). Whether GSK3
signaling is involved in Slit-induced axon branching is unknown.
However, regulated GSK3 inactivation is involved in Slit-mediated
neuronal migration (Higginbotham et al., 2006). In addition, the
GSK3 substrate CLASP has been shown to act downstream of Slit
to mediate axon repulsion (Lee et al., 2004). These results raise
the possibility that Slit regulates sensory axon branching via GSK3
signaling.
In addition to extracellular cues, recent studies have provided
evidence that intracellular molecules regulate axon branching
via GSK3 signaling. One study (Bilimoria et al., 2010) showed
that JNK-interacting protein 3 (JIP3) functioned to restrict axon
branching of mouse cerebellar neurons via GSK3 and its substrate
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doublecortin (DCX). Knocking down of JIP3 resulted in signif-
icantly increased axon branching and a reduced level of GSK3β,
protein suggesting that down-regulation of GSK3βmediated axon
branching-induced by JIP3 depletion (Figure 2). Consistent with
this idea, knocking down of GSK3β led to increased axon branch-
ing in a similar manner. Moreover, knocking down both JIP3
and GSK3β did not show an additive effect on axon branch-
ing, conﬁrming that they share the same pathway. Lastly, DCX
was identiﬁed as a substrate of GSK3β acting downstream of
JIP3 and GSK3β to restrict axon branching. Finally, A few studies
have demonstrated that PTEN deletion promotes axon branching
(Kwon et al., 2006; Drinjakovic et al., 2010). As down-regulation
of PTEN leads to increased activity of PI3K signaling, it is possible
that axon branching-induced by loss of PTEN is through GSK3
inactivation. Together, these studies indicate that GSK3 inactiva-
tion is a common mechanism by which both extracellular cues
and intracellular signals induce axon branching.
How GSK3 inactivation is translated into axon branching is
not fully understood. High-resolution time-lapse studies of F-
actin and microtubule dynamics indicate that coordinated reg-
ulation of F-actin reorganization and microtubule extension con-
trols branch formation, similar to what occurs in the growth
cone to drive axon elongation (Kalil et al., 2000; Dent and Kalil,
2001). At the growth cone, GSK3 inactivation is known to induce
growth cone enlargement (Owen and Gordon-Weeks, 2003; Kim
et al., 2006), presumably by promoting microtubule protrusion.
Increased growth cone size with enhanced microtubule protru-
sion may therefore result in increased growth cone splitting to
form axon branches. Along the axon shaft, axon branch formation
requires coordinated cytoskeletal reorganization, includingmicro-
tubule de-bundling and fragmentation, actin ﬁlopodia formation
followed by microtubule extension (Dent and Kalil, 2001). Local
inactivation of GSK3 along the axon shaft may promote these
cytoskeletal changes through various GSK3-regulated cytoskeletal
proteins. For instance, inactivation of GSK3 may modulate the
function of DCX (Bilimoria et al., 2010), which is known to reg-
ulate microtubule organization along the axon shaft (Bielas et al.,
2007; Tint et al., 2009; Figure 2). The microtubule severing pro-
tein Katanin is involved in microtubule fragmentation, a required
process for initiating the branch formation (Qiang et al., 2010).
The microtubule depolymerase KIF2a functions to impair micro-
tubule polymerization and thus limiting the extension of axon
branches (Homma et al., 2003). Interestingly, both Katanin and
KIF2a are potential GSK3 substrates (Taelman et al., 2010), sug-
gesting that inactivation of GSK3 may regulate their functions
to control axon branching. Moreover, local inactivation of GSK3
along the axonal shaft has been shown to induce local accumula-
tion of APC (Kim et al., 2006), which may stabilize polymerized
microtubules to promote axon branching.
CONCLUSION AND FUTURE DIRECTIONS
GSK3 is now considered to be a key signaling node molecule that
acts to regulate multiple steps of neuronal morphogenesis during
development by controlling a broad range of biological processes,
such as cellular transport, protein translation and degradation,
and cytoskeletal reorganization. Functions of GSK3 are achieved
through its large number of substrates and multiple modes of
regulation. Unlike most other kinases that are controlled by a sim-
ple activation/inactivation switch, it appears that regulation of
GSK3 is more complex. Different levels of GSK3 activities reg-
ulated by upstream signals may affect different substrates, thus
leading to distinct functions. Therefore, an important future direc-
tion is to identify and validate additional GSK3 substrates to
understand how speciﬁc functions of GSK3 signaling are achieved
via speciﬁc substrates. Moreover, the phosphorylation of GSK3
substrates is also regulated by various phosphatases, providing
another level of regulation of GSK3 signaling.
As neuronal morphogenesis is a dynamic process, the ability
to detect GSK3 activity at higher spatiotemporal resolution in live
cells is necessary to fully understand the roles of GSK3 signaling. In
addition to neuronal polarization, axon growth and axon branch-
ing,GSK3 signaling is also involved in other neuronalmorphogen-
esis processes, such as directed neuronalmigration, axon guidance,
dendrite development, and synaptogenesis. Futures studies are
necessary to establish the roles and the molecular mechanisms
by which GSK3 signaling control these developmental processes.
Finally, a number of neurological disorders, such as schizophre-
nia and autism, are associated with abnormal regulation of GSK3
signaling. It is therefore important in the future to identify the
potential links between the functions of GSK3 signaling in neural
development and the etiologies of these diseases.
The studies discussed in this review aremainly based on in vitro
experiments. Most in vitro preparations are highly reduced and
may not clearly reﬂect GSK3 functions in neurons in vivo, where a
myriad of surface molecules and growth factors are present and a
multiplicity of signaling pathways are active. Therefore, it is likely
that the details of the developmental regulation by GSK3 signal-
ing may not be entirely predictable from the in vitro studies that
have appeared to date. Recently, decisive mouse genetic models
(see other chapters) that enable cell-type speciﬁc GSK3 deletion
have been generated. The ﬁrst clear ﬁnding from these mice is
that the two family members GSK3α and GSK3β can compen-
sate for each other during brain development. Thus, when either
GSK3α or GSK3β alone is deleted, gross morphological develop-
ment proceeds. However, deletion of both family members results
in dramatic neurodevelopmental abnormalities (Kim et al., 2006).
The second clear ﬁnding is that GSK3 plays a major role in reg-
ulation of neural progenitors (Kim et al., 2009b). The neural
progenitor cells of GSK3 deleted mice show striking disruption
of apical–basal polarity, suggesting that GSK3 may also regulate
cytoskeletal reorganization of neural progenitors. Work on GSK3
regulation of postmitotic neurons in vivo is just beginning. Exper-
iments introducing constitutively activated GSK3 constructs via
in utero electroporation strongly suggest a key role of GSK3 signal-
ing in regulation of migration and cortical lamination (Asada and
Sanada, 2010). It can be expected that furtherworkwith thesemice
will generate a decisive view of in vivo GSK3 functions in develop-
mental processes discussed here, including neuronal polarization,
axon extension and branching, as well as other key developmen-
tal processes, such as axon guidance, dendritic arborization, and
synaptogenesis. However, it is important to keep in mind that
because the regulation of GSK3 is complex, knockout studies,
although very informative, may not fully reveal the molecular
mechanisms by which GSK3 regulates neural development.
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